Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-19-022427
Filing Date
2019-06-20
Accepted
2019-06-20 17:57:42
Documents
1
Period of Report
2019-06-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 2773
  Complete submission text file 0001127602-19-022427.txt   4419
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET, 6TH FLOOR NEW YORK NY 10014
Business Address
Rowinsky Eric K (Reporting) CIK: 0001318886 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 19909451